Global Infectious Disease Diagnostics Market

Global Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product(Reagents, Kits), By Test(Laboratory, POC), By Technology(Immunodiagnostics, Microbiology), By Disease(COVID-19, Hepatitis), By End-user(Diagnostic Laboratories, Hospitals & Clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35G2215 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 154 | Figures: 77

Global Infectious Disease Diagnostics Market Regional Insights

North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Infectious Disease Diagnostics Market size was valued at USD 27850.14 million in 2019 and is poised to grow from USD 29632.56 million in 2023 to USD 49041.76 million by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The Infectious Disease Diagnostics Market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the Infectious Disease Diagnostics Market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson, and Company. 'Abbott Laboratories', 'Becton, Dickinson and Company', 'bioMérieux SA', 'Bio-Rad Laboratories, Inc.', 'Cepheid Inc. (a Danaher Corporation Company)', 'F. Hoffmann-La Roche Ltd', 'Hologic, Inc.', 'Meridian Bioscience, Inc.', 'Qiagen N.V.', 'Siemens Healthineers AG', 'Thermo Fisher Scientific Inc.', 'Alere Inc.', 'Bruker Corporation', 'DiaSorin S.p.A.', 'Grifols S.A.', 'Luminex Corporation', 'Myriad Genetics, Inc.', 'Nanosphere Inc.', 'Quidel Corporation'

The prevalence of infectious diseases in developed and developing regions will have a positive impact on the infectious disease diagnostics market. The increasing number of prescriptions for infectious disease diagnostic tests is attributable to the diagnosis and management of such diseases. These factors, combined with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics over the forecast period.

Despite the enormous efforts put into infectious disease management, the development of low-cost, accurate, and sensitive POC products is in high demand. Nanotechnology has paved the way for widespread use in the healthcare industry. Several players have emphasized the introduction of POC platforms based on nanoparticles and Nanodevices.

North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Infectious Disease Diagnostics Market

Report ID: UCMIG35G2062 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Smart Cards In Healthcare Market
Buy Now GET FREE SAMPLE
Global Infectious Disease Diagnostics Market

Report ID: SQMIG35G2095 | Region: Global | Published Date: February, 2024 | Pages: 265 | Tables: 123 | Figures: 77

Global eClinical Solutions Market
Buy Now GET FREE SAMPLE
Global Infectious Disease Diagnostics Market

Report ID: SQMIG35G2269 | Region: Global | Published Date: February, 2024 | Pages: 219 | Tables: 94 | Figures: 76

Global Medical Electrodes Market
Buy Now GET FREE SAMPLE
Global Infectious Disease Diagnostics Market

Report ID: UCMIG35G2156 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Pharmacy Management System Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Infectious Disease Diagnostics Market

Product ID: SQMIG35G2215

$5,300
BUY NOW GET FREE SAMPLE